Immune correlates in a Phase II clinical trial with ipilimumab in combination with finite androgen deprivation therapy in patients with metastatic non-castrate prostate cancer

Immune correlates in a Phase II clinical trial with ipilimumab in combination with finite androgen deprivation therapy in patients with metastatic non-castrate prostate cancer - Descarga este documento en PDF. Documentación en PDF para descargar gratis. Disponible también para leer online.

Journal for ImmunoTherapy of Cancer

, 3:P106

First Online: 04 November 2015DOI: 10.1186-2051-1426-3-S2-P106

Cite this article as: Subudhi, S.K., Aparicio, A., Gao, J. et al. j. immunotherapy cancer 2015 3Suppl 2: P106. doi:10.1186-2051-1426-3-S2-P106 Download fulltext PDF

Autor: Sumit K Subudhi - Ana Aparicio - Jianjun Gao - Amado Zurita - Araujo John - Christopher Logothetis - Brinda Rao - Luis Ve

Fuente: https://link.springer.com/

DESCARGAR PDF

Documentos relacionados

Direct comparisons of T cell costimulation and checkpoint blockade in the setting of tumor-targeted monoclonal antibody therapy - Danny Khalil1

Incomplete meiotic sex chromosome inactivation in the domestic dog - Federica Federici - Eskeatnaf Mulugeta - Sam Schoenmakers - Evelyne Wassenaar - Jos W Hoogerbrugge - Godfried W van der He

Existence of Nash Equilibrium in Discontinuous Games - Nessah, Rabia

The oppression remedy: the Reasonable Expectations test and the economic theory of Incomplete Contracting - Kortbeek, Nancy L.

Transcriptional profile of sweet orange in response to chitosan and salicylic acid -

What Does Crypto-currency Look Like Gaining Insight into Bitcoin Phenomenon - Bouoiyour, Jamal